c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice

Culturing hippocampal neurons

Kaech, S., & Banker, G. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.356 · Cited by 1,766

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (1999) · Nature · doi:10.1038/45159 · Cited by 1,541

Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease

Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191

Culturing hippocampal neurons.

Tanaka, H. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.163 · Cited by 1,141

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

Cruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609

Regulation of the c-Abl and Bcr–Abl tyrosine kinases

Hantschel, O. D., & Superti‐Furga, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1280 · Cited by 500

A Hundred Years of Alzheimer's Disease Research

Hardy, J. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.016 · Cited by 467

Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation

Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A., & Baltimore, D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80646-7 · Cited by 397

Cables Links Cdk5 and c-Abl and Facilitates Cdk5 Tyrosine Phosphorylation, Kinase Upregulation, and Neurite Outgrowth

Zukerberg, L. R., Patrick, G. N., Nikolić, M., Humbert, S., Wu, C., Lanier, L. M., Gertler, F. B., Vidal, M., Etten, R. A. V., & Tsai, L. (2000) · Neuron · doi:10.1016/s0896-6273(00)81200-3 · Cited by 396

Oxidative stress, mitochondrial damage and neurodegenerative diseases.

Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,371

The importance of tau phosphorylation for neurodegenerative diseases

Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475

The Role of Cdk5 in Alzheimer’s Disease

Liu, S., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 274

Drug repositioning: Progress and challenges in drug discovery for various diseases

Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232

Cdk5 activity in the brain – multiple paths of regulation

Shah, K., & Lahiri, D. K. (2014) · Journal of Cell Science · doi:10.1242/jcs.147553 · Cited by 205

The role of tau kinases in Alzheimer's disease.

Dolan, P. J., & Johnson, G. V. W. (2010) · PubMed · Cited by 178

Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of A lzheimer's Disease

Tapia‐Rojas, C., Aránguiz, F. C., Varela‐Nallar, L., & Inestrosa, N. C. (2015) · Brain Pathology · doi:10.1111/bpa.12255 · Cited by 176

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials

Basheer, N., Smolek, T., Hassan, I., Liu, F., Iqbal, K., Zilka, N., & Novak, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02113-z · Cited by 159

Tyrosine kinase inhibition increases functional parkin‐Beclin‐1 interaction and enhances amyloid clearance and cognitive performance

Lonskaya, I., Hebron, M. L., Desforges, N. M., Franjie, A., & Moussa, C. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302771 · Cited by 143

Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice

Liu, H., Zhao, G., Zhang, H., & Li-de, S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.008 · Cited by 145

c-Abl in Neurodegenerative Disease

Schlatterer, S. D., Acker, C. M., & Davies, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9588-1 · Cited by 127

The c-Abl-MST1 Signaling Pathway Mediates Oxidative Stress-Induced Neuronal Cell Death

Xiao, L., Chen, D., Hu, P., Wu, J., Liu, W., Zhao, Y. L., Cao, M., Fang, Y., Bi, W., Zheng, Z., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0035-11.2011 · Cited by 125

Regulation and role of cyclin‐dependent kinase activity in neuronal survival and death

Hisanaga, S., & Endo, R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07050.x · Cited by 120

Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer’s disease

Manocha, G. D., & Combs, C. K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-117 · Cited by 122

Nuclear envelope dysfunction and its contribution to the aging process

Martins, F., Sousa, J., Pereira, C. D., Silva, O. A. B. D. C. E., & Rebelo, S. (2020) · Aging Cell · doi:10.1111/acel.13143 · Cited by 114

Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism

Manocha, G. D., Floden, A. M., & Combs, C. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.027 · Cited by 110

Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease

La Barbera, L., Vedele, F., Nobili, A., Krashia, P., Spoleti, E., Latagliata, E. C., Cutuli, D., Cauzzi, E., Marino, R., Viscomi, M. T., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102031 · Cited by 98

Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality

Hu, Z., Chen, P.-H., Li, W., Douglas, T., Hines, J., Liu, Y., & Crews, C. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11706 · Cited by 98

Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling

Rojas, F., González, D., Cortés, N., Ampuero, E., Hernández, D. E., Fritz, E., Abarzúa, S., Martinez, A. N., Elorza, Á. A., Alvarez, A. R., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00203 · Cited by 97

c-Abl Stabilizes HDAC2 Levels by Tyrosine Phosphorylation Repressing Neuronal Gene Expression in Alzheimer’s Disease

Gonzalez-Zuñiga, M., Contreras, P. S., Estrada, L. D., Chamorro, D., Villagra, A., Zanlungo, S., Seto, E., & Alvarez, A. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.013 · Cited by 91

EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers

M. Vargas, L., Leal, N., Estrada, L. D., González, A., Serrano, F., Araya, K., Gysling, K., Inestrosa, N. C., Pasquale, E. B., & Alvarez, A. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092309 · Cited by 85

The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model

Lee, S., Kim, S., Park, Y. J., Yun, S. P., Kwon, S., Kim, D., Kim, D.-Y., Shin, J. S., Cho, D. J., Lee, G. Y., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy143 · Cited by 81

c-Abl–p38α signaling plays an important role in MPTP-induced neuronal death

Wu, R., Chen, H., Ma, J., He, Q., Huang, Q., Liu, Q., Li, M., & Yuan, Z. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.135 · Cited by 82

Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease

Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98

Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88

Hypoxia Increases Aβ-Induced Tau Phosphorylation by Calpain and Promotes Behavioral Consequences in AD Transgenic Mice

Gao, L., Tian, S., Gao, H.-H., & Xu, Y.-Y. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9966-y · Cited by 81

Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons

Quintanilla, R. A., Rommy von Bernhardi, M., Godoy, J. A., Inestrosa, N. C., & Johnson, G. V. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.016 · Cited by 70

Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms

Du, Y., Qu, J., Zhang, W., Bai, M., Zhou, Q., Zhang, Z., Li, Z., & Miao, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.008 · Cited by 72

Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity

Chen, J., Li, S., Sun, W.-S., & Li, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123864 · Cited by 70

Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease

Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 71

Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses

Wilkaniec, A., Czapski, G. A., & Adamczyk, A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13365 · Cited by 69

Neuronal c-Abl Overexpression Leads to Neuronal Loss and Neuroinflammation in the Mouse Forebrain

Schlatterer, S. D., Tremblay, M. A., Acker, C. M., & Davies, P. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102025 · Cited by 65

Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing

Inestrosa, N. C., Tapia‐Rojas, C., Griffith, T. N., Carvajal, F. J., Benito, M. J., Rivera-Dictter, A., Alvarez, A. R., Serrano, F. G., Hancke, J. L., Burgos, P. V., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.19 · Cited by 65

Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress

Ciccone, S., Maiani, E., Bellusci, G., Diederich, M. F., & Gonfloni, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022388 · Cited by 67

c-Abl Tyrosine Kinase Mediates Neurotoxic Prion Peptide-Induced Neuronal Apoptosis via Regulating Mitochondrial Homeostasis

Pan, B., Yang, L., Wang, J., Wang, Y., Wang, J., Zhou, X., Yin, X., Zhang, Z., & Zhao, D. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8646-4 · Cited by 54

Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways

Hu, J.-P., Xie, J., Wang, C., Wang, T., Wang, X., Wang, S., Teng, W., & Wang, Z. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.03.006 · Cited by 60

Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling Pathway

Liu, W., Wu, J., Xiao, L., Bai, Y., Qu, A., Zheng, Z., & Yuan, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036562 · Cited by 60

Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse

Zhao, H., Chang, R., Che, H., Wang, J., Yang, L., Wei, F., Xia, Y., Li, N., Ma, Q., & Wang, X. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.026 · Cited by 53

Tau clearance improves astrocytic function and brain glutamate-glutamine cycle

Hebron, M. L., Javidnia, M., & Moussa, C. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.06.005 · Cited by 50

Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease

Padhi, D., & Govindaraju, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00335 · Cited by 47

Expanding spectrum of anticancer drug, imatinib, in the disorders affecting brain and spinal cord

Kumar, M., Kulshrestha, R., Singh, N., & Jaggi, A. S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.014 · Cited by 46

c-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder

Contreras, P. S., Tapía, P., González-Hódar, L., Peluso, I., Soldati, C., Napolitano, G., Matarese, M., Heras, M. L., Valls, C., Martinez, A. N., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101691 · Cited by 45

Targeting dementias through cancer kinases inhibition

Fagiani, F., Lanni, C., Racchi, M., & Govoni, S. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12044 · Cited by 43

STI571 protects neuronal cells from neurotoxic prion protein fragment-induced apoptosis

Pan, Y., Sun, L., Wang, J., Fu, W., Fu, Y., Wang, J., Tong, Y., & Pan, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.029 · Cited by 33

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer¿s disease correlates with pathology

Rosenberger, A. F. N., Rozemüller, A. J. M., van der Flier, W. M., Scheltens, P., van der Vies, S. M., & Hoozemans, J. J. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0079-9 · Cited by 40

Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer’s disease

Olabarria, M., Pasini, S., Corona, C., Robador, P. A., Song, C., Patel, H., & Lefort, R. (2019) · Communications Biology · doi:10.1038/s42003-019-0350-5 · Cited by 41

Tau‐targeting nanoparticles for treatment of Alzheimer's disease

Pawar, S., Rauf, M. A., Abdelhady, H. G., & Iyer, A. K. (2024) · Exploration · doi:10.1002/exp.20230137 · Cited by 42

Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice

Yu, L., Liu, Y., Jin, Y., Cao, X., Chen, J., Jin, J., Gu, Y., Bao, X., Ren, Z., Xu, Y., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170844 · Cited by 37

Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation

Acosta, D. M., Mancinelli, C. D., Bracken, C., & Eliezer, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101442 · Cited by 36

The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies

Motaln, H., & Rogelj, B. (2023) · Cells · doi:10.3390/cells12162041 · Cited by 32

High NaCl–induced activation of CDK5 increases phosphorylation of the osmoprotective transcription factor TonEBP/OREBP at threonine 135, which contributes to its rapid nuclear localization

Gallazzini, M., Heussler, G. E., Kunin, M., Izumi, Y., Burg, M. B., & Ferraris, J. D. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0681 · Cited by 31

Cdk5: A main culprit in neurodegeneration

Gupta, K. K., & Singh, S. K. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1645142 · Cited by 32

Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide

Gardner, L. E., White, J. D., Eimerbrink, M. J., Boehm, G. W., & Chumley, M. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.007 · Cited by 29

c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases

Gutiérrez, D. A., Chandía-Cristi, A., Yañez, M. J., Zanlungo, S., & Alvarez, A. R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346540 · Cited by 31

Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy

Javidnia, M., Hebron, M. L., Xin, Y., Kinney, N. G., & Moussa, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170429 · Cited by 30

Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions

Yañez, M. J., Marín, T., Balboa, E., Klein, A. D., Alvarez, A. R., & Zanlungo, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165875 · Cited by 30

Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium

Guttuso, T. J., Andrzejewski, K. L., Lichter, D. G., & Andersen, J. K. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.05.016 · Cited by 29

Therapeutic Potential of the Hsp90/Cdc37 Interaction in Neurodegenerative Diseases

Gracia, L., Lora, G., Blair, L. J., & Jinwal, U. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01263 · Cited by 29

TYK2 regulates tau levels, phosphorylation and aggregation in a tauopathy mouse model

Kim, J., Tadros, B., Liang, Y. H. W., Kim, Y. D., Lasagna‐Reeves, C. A., Sonn, J. Y., Chung, D. C., Hyman, B. T., Holtzman, D. M., & Zoghbi, H. Y. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01777-2 · Cited by 28

p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease

Cancino, G. I., Miller, F. D., & Kaplan, D. R. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.010 · Cited by 27

The Emerging Role of Cables1 in Cancer and Other Diseases

Huang, J.-R., Tan, G., Li, Y., & Shi, Z. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107730 · Cited by 24

High-Performance Extended-Gate Field-Effect Transistor for Kinase Sensing in Aβ Accumulation of Alzheimer’s Disease

Peng, Q., Zhang, M., & Shi, G. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c05164 · Cited by 23

c-Abl activates RIPK3 signaling in Gaucher disease

Yañez, M. J., Campos, F., Marín, T., Klein, A. D., Futerman, A. H., Alvarez, A. R., & Zanlungo, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166089 · Cited by 24

Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders

Tian, Z., Feng, B., Wang, X.-Q., & Tian, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1030639 · Cited by 23

The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer’s disease

Patricio-Martínez, A., Patricio, F., Macuil-Chapuli, E., Martínez-Juárez, E. Á., Flores-Díaz, S., Cedillo-Ramirez, M. L., & Limón, I. D. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1598011 · Cited by 23

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease

Timmons, J. A., Anighoro, A., Brogan, R. J., Stahl, J., Wahlestedt, C., Farquhar, D. G., Taylor‐King, J. P., Volmar, C., Kraus, W. E., & Phillips, S. M. (2021) · eLife · doi:10.7554/elife.68832 · Cited by 21

Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress

Jiang, L., Chakraborty, P., Zhang, L., Wong, M., Hill, S. E., Webber, C. J., Libera, J., Blair, L. J., Wolozin, B. L., & Zweckstetter, M. (2023) · Science Advances · doi:10.1126/sciadv.add9789 · Cited by 19

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease

León-Martínez, R., Gutiérrez, D. A., Pinto, C., Morales, C., de la Fuente, C., Riquelme, C., Cortés, B. I., González-Martín, A., Chamorro, D., Espinosa, N., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1180987 · Cited by 19

Neuroprotective potential of imatinib in global ischemia-reperfusion-induced cerebral injury: possible role of Janus-activated kinase 2/signal transducer and activator of transcription 3 and connexin 43

Wang, J., Bai, T., Wang, N., Li, H., & Guo, X. (2020) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2020.24.1.11 · Cited by 18

Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases

Shu, L., Du, C., & Zuo, Y. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad066 · Cited by 17

Altered expression of c-Abl in patients with epilepsy and in a rat model

Chen, L., Wang, Z., Tang, B., Fang, M., Li, J., Chen, G., & Wang, X. (2014) · Synapse · doi:10.1002/syn.21741 · Cited by 15

The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model

Marín, T., Valls, C., Jerez, C., Huerta, T., Elgueta, D., Vidal, R. L., Alvarez, A. R., & Cancino, G. I. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.10.006 · Cited by 14

Abelson Kinases Mediate the Depression of Spontaneous Synaptic Activity Induced by Amyloid Beta 1–42 Peptides

Reichenstein, M., Borovok, N., Sheinin, A., Brider, T., & Michaelevski, I. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00858-7 · Cited by 13

A common molecular and cellular pathway in developing Alzheimer and cancer

Ali, M., Wani, S. U. D., Dey, T., Sridhar, S. B., & QADRIE, Z. L. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101625 · Cited by 14

c-Abl regulates a synaptic plasticity-related transcriptional program involved in memory and learning

González-Martín, A., Moyano, T. C., Gutiérrez, D. A., Carvajal, F. J., Cerpa, W. F., Hanley, J. G., Gutiérrez, R. A., & Alvarez, A. R. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102122 · Cited by 12

c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation

Lee, S., Ryu, H. G., Kweon, S. H., Kim, H., Park, H., Lee, K., Jang, S., Na, C. H., Kim, S., & Ko, H. S. (2022) · Cells · doi:10.3390/cells11243972 · Cited by 12

c-Abl Phosphorylates MFN2 to Regulate Mitochondrial Morphology in Cells under Endoplasmic Reticulum and Oxidative Stress, Impacting Cell Survival and Neurodegeneration

Martinez, A. N., Lamaizon, C. M., Valls, C., Llambi, F., Leal, N. R., Fitzgerald, P., Guy, C. S., Kamiński, M. M., Inestrosa, N. C., van Zundert, B., et al. (2023) · Antioxidants · doi:10.3390/antiox12112007 · Cited by 12

c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth

Chandía-Cristi, A., Stuardo, N., Trejos, C., Leal, N. R., Urrutia, D., Bronfman, F. C., & Rojas, A. Á. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031944 · Cited by 13

The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid‐β, Oxidative Stress, and Neuroinflammation

Zamanian, M. Y., Khachatryan, L., Heidari, M., Darabi, R., Golmohammadi, M., Al-Aouadi, R. F. A., & Akkol, E. K. (2025) · BioFactors · doi:10.1002/biof.70047 · Cited by 14

Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia

Claudiani, S., Apperley, J. F., Deplano, S., Khorashad, J. S., Foroni, L., Palanicawandar, R., Perry, R. J., & Milojković, D. (2016) · American Journal of Hematology · doi:10.1002/ajh.24495 · Cited by 11

Substrate-Selective Positive Allosteric Modulation of Ptprd's Phosphatase by FlavonolsPreprint

Henderson, I. M., Marez, C., Dokładny, K., Smoake, J., Martinez, M., Johnson, D. K., & Uhl, G. R. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4065674 · Cited by 11

The Hippo signaling pathway as a therapeutic target in Alzheimer’s disease

Chen, D., Wigglesworth-Littlewood, S., & Gunn‐Moore, F. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00891-4 · Cited by 10

Roles for c-Abl in postoperative neurodegeneration

Feng, L., Fu, S., Yao, Y., Li, Y., Xu, L., Zhao, Y., & Luo, L. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.73740 · Cited by 12

Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease

Zhong, M., Xu, Q., Hu, Z. J., Yang, W., Lin, Z., & Xian, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118113 · Cited by 10

Does the small tyrosine kinase inhibitor imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?

Welsh, N. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.724398 · Cited by 9

Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders

Angela Asir, R., V, Buzaeva, P., & Michaelevski, I. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.100892 · Cited by 8

SC75741, A Novel c-Abl Inhibitor, Promotes the Clearance of TDP25 Aggregates via ATG5-Dependent Autophagy Pathway

Zhou, D., Yan, H., Yang, S., Zhang, Y., Xu, X., Cen, X., Lei, K., & Xia, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.741219 · Cited by 8

Role of proline‐rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease

Kumar, R. K., Tiwari, V., & Dey, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15569 · Cited by 9

Identification of abelson tyrosine kinase inhibitors as potential therapeutics for Alzheimer’s disease using multiple e-pharmacophore modeling and molecular dynamics

Palakurti, R., & Vadrevu, R. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1166454 · Cited by 8

Repurposing of Kinase Inhibitors to Target c-Abl as Potential Therapeutics for Alzheimer’s Disease

Zhu, Q., Chen, J., Wu, X. L., Jin, X., & Ruan, B. (2014) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-014-9202-5 · Cited by 7

Imatinib in Targeted Therapy: Advances in Biomedical Applications and Drug Delivery Systems

Gvozdeva, Y., Georgieva, P., & Katsarov, P. (2025) · Hemato · doi:10.3390/hemato6040040 · Cited by 5

Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I:C administration

White, J. D., Eimerbrink, M. J., Hayes, H. B., Hardy, A., Enkevort, E. A. V., Peterman, J. L., Chumley, M. J., & Boehm, G. W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.032 · Cited by 7

Propofol inhibits the expression of Abelson nonreceptor tyrosine kinase without affecting learning or memory function in neonatal rats

Feng, L., Sun, Z., Liu, Q., Ma, T., Xu, Z., Feng, Z., Yuan, W., Zhang, H., & Xu, L. (2020) · Brain and Behavior · doi:10.1002/brb3.1810 · Cited by 5

Ptprd deficiency promotes tau hyperphosphorylation and impairs cognitive function in aged mice

Foncea-Bitrán, A., Franchini, N., Tobar, I., Thienel, S., Retamal, I. N., Cancino, G. I., & Cornejo, F. (2025) · Biological Research · doi:10.1186/s40659-025-00607-4 · Cited by 4

Exploring the anti-stress effects of imatinib and tetrabenazine in cold-water immersion-induced acute stress in mice

Kumar, M., Singh, N., & Jaggi, A. S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01862-w · Cited by 4

The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic

Mansour, H. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102195 · Cited by 3

Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer’s disease

Layal, H., Rajbongshi, J., Kumar, R., Pandey, S., Mishra, R., & Yadav, P. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.057 · Cited by 4

What is the Link Between Protein Aggregation and Interneuronal Lesion Propagation in Neurodegenerative Disease?

Garth, F. (2011) · InTech eBooks · doi:10.5772/27973 · Cited by 3

Reciprocal c-Abl-GPx1 regulation controls CA1 neuronal viability to oxidative stress via ERK1/2-DRP1-mediated mitochondrial dynamics

Kim, J.-E., Wang, S. H., & Kang, T. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110586 · Cited by 2

Alzheimer’s disease prevention by flavonols and their analogs

Uhl, G. R., Kannan, B., Choi, J., & Henderson, I. M. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100361 · Cited by 2

P2‐214: c‐Abl kinase activation regulates both the neuronal death and the tau phosphorylation in Alzhemier's disease models

Alvarez, A. R., de Arce, K. P., & Cancino, G. I. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1263

The localization of c-Abl in Alzheimer's disease

Jing, Z. (2008) · D-Scholarship@Pitt (University of Pittsburgh)

STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's β-amyloid deposits

Cancino, G. I., Toledo, E. M., Leal, N. R., Hernández, D. E., Yévenes, L. F., Inestrosa, N. C., & Alvarez, A. R. (2008) · Brain · doi:10.1093/brain/awn125 · Cited by 147

P1‐160: Neurodegeneration as a consequence of expression of active c‐abl in the adult mouse brain

Schlatterer, S. D., Tremblay, M. A., Acker, C. M., & Davies, P. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.710

C-Abl Tyrosine Kinase Signaling: A New Player in AD Tau Pathology

Estrada, L. D., Zanlungo, S., & Alvarez, A. R. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717249 · Cited by 18